Pages that link to "Q42981905"
Jump to navigation
Jump to search
The following pages link to Thomas Berg (Q42981905):
Displaying 50 items.
- Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis (Q24645261) (← links)
- Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences (Q27477971) (← links)
- Expert opinion on the treatment of patients with chronic hepatitis C (Q27489903) (← links)
- Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study (Q28269827) (← links)
- IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study (Q28477057) (← links)
- Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort (Q28478435) (← links)
- High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients (Q28481558) (← links)
- Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients (Q28539645) (← links)
- Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy (Q30441653) (← links)
- Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores (Q30465393) (← links)
- A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis (Q30815377) (← links)
- Retrospective cohort study of lamivudine therapy in patients with chronic hepatitis B (Q32064569) (← links)
- [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases]. (Q33181432) (← links)
- Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance. (Q33184311) (← links)
- Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver (Q33364279) (← links)
- Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. (Q33377599) (← links)
- A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C. (Q33414941) (← links)
- Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality (Q33582313) (← links)
- Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans (Q33943907) (← links)
- The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis (Q34075498) (← links)
- Viscoelasticity-based Staging of Hepatic Fibrosis with Multifrequency MR Elastography (Q34129273) (← links)
- A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis (Q34140192) (← links)
- TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients. (Q34188474) (← links)
- A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. (Q34341819) (← links)
- Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C. (Q34506224) (← links)
- Acute liver failure following the use of ecstasy (MDMA) (Q34527536) (← links)
- The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage? (Q34626108) (← links)
- Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development (Q34755326) (← links)
- First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome (Q34794063) (← links)
- Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B. (Q34797281) (← links)
- Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent (Q35049299) (← links)
- Computational methods for the design of effective therapies against drug resistant HIV strains (Q36250187) (← links)
- Fatal outcome of hepatitis A virus (HAV) infection in a traveler with incomplete HAV vaccination and evidence of Rift Valley Fever virus infection (Q36957867) (← links)
- Application of qualitative and quantitative real-time PCR, direct sequencing, and terminal restriction fragment length polymorphism analysis for detection and identification of polymicrobial 16S rRNA genes in ascites (Q37713786) (← links)
- Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. (Q37764165) (← links)
- Intrahepatic cholestasis in common chronic liver diseases. (Q38127461) (← links)
- Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. (Q38731224) (← links)
- A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease (Q38982903) (← links)
- Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication (Q39349271) (← links)
- Invasive cardiac aspergillosis after orthotopic liver transplantation (Q39597353) (← links)
- Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice (Q39639458) (← links)
- Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system (Q39756691) (← links)
- Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. (Q40099630) (← links)
- Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study (Q40111501) (← links)
- Effects of stepped psychooncological care on referral to psychosocial services and emotional well-being in cancer patients: A cluster-randomized phase III trial (Q40139819) (← links)
- The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. (Q40157059) (← links)
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials (Q40251971) (← links)
- IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis (Q40258100) (← links)
- Percutaneous transjugular direct porto-caval shunt in patients with Budd-Chiari syndrome. (Q40321823) (← links)
- SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patients (Q41077060) (← links)